Hutchmed Drc Stock Today
| HCM Stock | USD 15.69 0.32 2.08% |
PerformanceInsignificant
| Odds Of DistressLow
|
HUTCHMED DRC is selling at 15.69 as of the 17th of March 2025; that is 2.08 percent increase since the beginning of the trading day. The stock's lowest day price was 15.49. HUTCHMED DRC has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat insignificant performance during the last 90 days. The performance scores are derived for the period starting the 17th of December 2024 and ending today, the 17th of March 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 17th of March 2016 | Category Healthcare | Classification Health Care |
HUTCHMED Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. The company was incorporated in 2000 and is headquartered in Central, Hong Kong. Hutchmed China operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. The company has 170.94 M outstanding shares of which 402.76 K shares are currently shorted by investors with about 4.81 days to cover. More on HUTCHMED DRC
Moving against HUTCHMED Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
HUTCHMED Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| Thematic Ideas | (View all Themes) | ||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Biotechnology, NASDAQ Composite, NASDAQ Health Care, VN Index, VN100, VN All Shares, VN Mid Cap, Drugs, Cancer Fighters, Health Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) | ||||
| Average Analyst Recommendation | |||||
Debt LevelsHUTCHMED DRC can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand HUTCHMED DRC's financial leverage. It provides some insight into what part of HUTCHMED DRC's total assets is financed by creditors.
| |||||
HUTCHMED DRC (HCM) is traded on NASDAQ Exchange in USA. It is located in Cheung Kong Center, Hong Kong, Hong Kong and employs 1,970 people. HUTCHMED DRC is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a total capitalization of 2.68 B. HUTCHMED DRC runs under Pharmaceuticals sector within Health Care industry. The entity has 170.94 M outstanding shares of which 402.76 K shares are currently shorted by investors with about 4.81 days to cover.
HUTCHMED DRC has about 829.71 M in cash with 219.26 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.91.
Check HUTCHMED DRC Probability Of Bankruptcy
Ownership AllocationHUTCHMED DRC has a total of 170.94 Million outstanding shares. Roughly 95.83 (percent) of HUTCHMED DRC outstanding shares are held by general public with 0.12 % owned by insiders and only 4.05 pct. by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check HUTCHMED Ownership Details
HUTCHMED Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Goldman Sachs Group Inc | 2024-12-31 | 86.6 K | |
| Hennion & Walsh Asset Management Inc | 2024-12-31 | 60 K | |
| Two Sigma Investments Llc | 2024-12-31 | 58.5 K | |
| Xy Capital Ltd | 2024-12-31 | 46.7 K | |
| D. E. Shaw & Co Lp | 2024-12-31 | 41.5 K | |
| Dekabank Deutsche Girozentrale | 2024-12-31 | 41.4 K | |
| Bnp Paribas Arbitrage, Sa | 2024-12-31 | 39.6 K | |
| Citadel Advisors Llc | 2024-12-31 | 36.5 K | |
| Abc Arbitrage Sa | 2024-12-31 | 34.7 K | |
| Schroder Investment Management Group | 2024-12-31 | 2.8 M | |
| Allianz Asset Management Ag | 2024-12-31 | 1.1 M |
HUTCHMED DRC Historical Income Statement
HUTCHMED Stock Against Markets
HUTCHMED DRC Corporate Management
| Kin MBA | Senior Communications | Profile | |
| CA BEc | CFO Director | Profile | |
| CS CGP | Company Director | Profile | |
| Yiling Cui | Executive Operations | Profile | |
| Charles Nixon | Group Counsel | Profile | |
| Qingmei Wang | Senior Alliances | Profile |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in HUTCHMED DRC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in HUTCHMED Stock, please use our How to Invest in HUTCHMED DRC guide.You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of HUTCHMED DRC. If investors know HUTCHMED will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about HUTCHMED DRC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.84) | Earnings Share (0.25) | Revenue Per Share | Quarterly Revenue Growth (0.43) | Return On Assets |
The market value of HUTCHMED DRC is measured differently than its book value, which is the value of HUTCHMED that is recorded on the company's balance sheet. Investors also form their own opinion of HUTCHMED DRC's value that differs from its market value or its book value, called intrinsic value, which is HUTCHMED DRC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because HUTCHMED DRC's market value can be influenced by many factors that don't directly affect HUTCHMED DRC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between HUTCHMED DRC's value and its price as these two are different measures arrived at by different means. Investors typically determine if HUTCHMED DRC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, HUTCHMED DRC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.